The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liposomal irinotecan plus cisplatin/carboplatin as second-line therapy for platinum-sensitive relapsed extensive-stage small cell lung cancer: Interim results of a phase II trial.
 
Jie Min
No Relationships to Disclose
 
Lili Liu
No Relationships to Disclose
 
Ningqiang Ma
No Relationships to Disclose
 
Jian Fu
No Relationships to Disclose
 
Lin Deng
No Relationships to Disclose
 
Xue Yang
No Relationships to Disclose
 
Feng Zhang
No Relationships to Disclose
 
Yanxia Kang
No Relationships to Disclose
 
Chenggong Liao
No Relationships to Disclose
 
Yaning Zhao
No Relationships to Disclose
 
Yang Song
No Relationships to Disclose
 
Haichuan Su
No Relationships to Disclose